Across the tech ecosystem, organizations are coalescing around a shared vision: The smarter future of AI lies at the edge.

Anthropic research reveals AI models perform worse with extended reasoning time, challenging industry assumptions about test-time compute scaling in enterprise deployments.

In contrast to AI-driven drug discovery companies like Xaira, Recursion, or DeepMind spinout Isomorphic Labs, which focus on ...

Generative AI, especially large language models (LLMs), present exciting and unprecedented opportunities and complex ...

This precision medicine approach, driven by granular, real-world evidence, is critical for reshaping clinical guidelines and ...